Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national
4
×
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
democrats
fda
medical device
novartis
republicans
abbvie
actavalon
acute myeloid leukemia
adaptive biotechnologies
aileron therapeutics
alicrocumab
What
public
4
×
ipo
firms
life
science
week
america
answer
away
bio
biogen
biotechs
blood
broader
cancer
club
companies
company
continued
continues
convoluted
crop
democratic
democrats
dems
detect
developing
discontent
dreams
drugs
election
exceeded
files
grail
group
haul
head
headaches
healthcare
high
Language
unset
Current search:
public
×
national
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
